Wei‐Yu Liao

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

Chao‐Chi Ho, Wei‐Yu Liao, Chih-An Lin et al. · Journal of Thoracic Oncology · 2016 · 216 citations

Resistant Mechanism, Sclerostin, Genetic Disorder +4

TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer

Chao‐Chi Ho, Wei‐Yu Liao, Yin-Hsiu Lu et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 144 citations

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Chia‐Chi Lin, Jin‐Yuan Shih, Chong‐Jen Yu et al. · The Lancet Respiratory Medicine · 2017 · 143 citations

Oncology, Non-small-cell Lung Cancer, Somatic Variant +11

Chromosomal aberrations and gene expression profiles in non-small cell lung cancer

Elinor Dehan, Amir Ben‐Dor, Wei‐Yu Liao et al. · Lung Cancer · 2007 · 140 citations

Chromatin, Oncology, Tumor Heterogeneity +11

Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan

Kuo-Hsuan Hsu, Chao‐Chi Ho, Te‐Chun Hsia et al. · PLoS ONE · 2015 · 115 citations · Full text